封面
市场调查报告书
商品编码
1401976

2030 年神经电路市场预测:按产品类型、应用、最终用户和地区进行的全球分析

Neuronal Circuits Market Forecasts to 2030 - Global Analysis By Product Type (Neurotechnology Devices, Neurodiagnostics, Neurotherapeutics, Electrodes and Probes and Other Product Types), Type, Application, End User and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据,2023 年全球神经电路市场规模为 1.947 亿美元,预计到 2030 年将达到 7.017 亿美元,预测期内复合年增长率为 20.1%。

神经刺激设备、神经调节技术和其他用于治疗帕金森氏症、忧郁症和慢性疼痛等疾病的介入措施。成像技术、电极、探针、神经刺激设备和神经技术的进步只是众多可用工具和解决方案的一小部分。理解、修改和利用神经系统中的神经迴路是神经迴路市场的焦点,其中包括相关技术和产品的研究、开发和商业化。

扩大神经科学研究的投资

政府机构、私人投资者和製药公司不断增加的资金正在推动旨在理解和修改神经网路的最尖端科技的创新和创造。这些投资支持探索神经系统疾病、大脑功能的复杂性和潜在治疗方法的研究。此外,更多的资金允许研究人员进行更长时间、更深入的研究,使他们能够开发尖端仪器和设备并发现新的见解。马苏。

缺乏标准化

临床应用和研究中缺乏标准方法、方法论和报告方法抑制了结果的可比较性和再现性。这种多样性使得理解资料和创建检查神经元内神经迴路的标准流程变得困难。不仅机构和研究人员的合作变得更加困难,而且缺乏标准将使研究成果转化为治疗应用变得更加复杂。标准化对于确保资料的真实性和可靠性、促进跨学科合作以及加速可有效整合到医疗程序中的神经技术的开发至关重要。

人口高龄化加剧

随着老年人口数量的增加,阿兹海默症、帕金森氏症和认知能力下降等与老龄化相关的神经系统疾病在国际上呈上升趋势。随着人口老化的增加,迫切需要能够解决老年人复杂神经迴路问题的创新诊断设备、治疗方法和神经刺激设备。此外,这些人口变化凸显了神经科学研究和开发的必要性,以提供适合高龄化社会需求的解决方案。

临床实务中的多种功效

儘管这些治疗方法在治疗神经系统疾病方面显示出前景,但其有效性却存在差异。治疗结果的不可预测性是由于多种因素造成的,包括人类异质性、神经迴路的复杂结构、神经系统疾病的动态性质。这种可变性使得医疗专业人员很难预测和最大化治疗效果。可靠且一致的结果需要深入了解每个大脑迴路的独特特性、个体化的治疗计划以及进一步的研究以改进和标准化技术。

COVID-19 的影响:

与大流行相关的实验室关闭以及将资源重新分配给与大流行相关的工作,对研究和开发造成了严重干扰。此外,招募患者和使用研究设施方面的困难推迟了针对神经迴路的新神经技术的临床试验。此外,这场流行病提高了人们对心理健康问题的认识,导致人们对神经技术的兴趣和投资增加,以解决忧郁症和焦虑等问题。

神经技术设备产业预计将在预测期内成为最大的产业

由于显着的技术开拓以及对神经迴路在神经功能中发挥的关键作用的日益了解,神经技术设备占据了最大的市场占有率。脑机介面 (BCI)、神经介面、神经刺激设备和矫正器具只是神经技术设备这一大类众多发展成果中的一小部分。此外,这些设备正在引领神经科学研究、治疗和诊断的变革。透过修改特定的神经迴路,深部脑部刺激(DBS)和经颅磁刺激(TMS)等神经刺激设备越来越多地用于治疗神经系统疾病。

预计马达电路领域在预测期内将经历最高的复合年增长率。

由于人们对运动功能复杂性的认识不断提高以及对尖端治疗方法的需求不断增加,运动电路领域有望盈利增长。这种扩散尤其值得注意,因为针对运动迴路的神经技术的发展和使用突显了这些迴路在运动控制和协调中所扮演的关键角色。此外,运动电路部分涵盖了神经假体和脑机介面(BCI)的进展,这些技术直接与运动相关的神经电路连接,并为迷路或瘫痪的人提供运动功能。

占有率最大的地区

亚太地区占据了最大的占有率,因为该地区国家透过对研发的大量投资和医疗基础设施的快速改善而在神经技术创新领域主导地位。对神经系统疾病的了解不断加深,以及影响神经迴路的疾病发生率不断增加,增加了对创新诊断和治疗方法的需求。此外,透过加强学术机构、研究机构和产业贡献者之间的合作努力和伙伴关係,亚太地区正在建立一个充满活力的神经科学研究生态系统。

复合年增长率最高的地区:

由于对研究经费、医疗基础设施和合作研究的关注,欧洲地区预计将出现良好的成长。欧洲国家正在大力投资神经迴路研究,从而促进我们对大脑运作方式的理解和最尖端科技的发展。此外,政府对神经科学计画的融资和策略性投资也推动了尖端神经迴路技术的发展,为研究和开发创造了良好的环境。

免费客製化服务:

订阅此报告的客户可以利用以下免费自订选项之一:

  • 公司简介
    • 其他市场参与企业的综合分析(最多 3 家公司)
    • 主要企业SWOT分析(最多3家企业)
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计/预测/复合年增长率(註:基于可行性检查)
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 介绍
  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病(COVID-19)的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球神经电路市场:依产品类型

  • 介绍
  • 神经技术设备
  • 神经诊断
  • 神经治疗
  • 电极和探针
    • 微电极阵列
    • 多电极阵列
    • 膜片钳电极
  • 神经刺激设备
    • 深部脑部刺激(DBS)
    • 经颅磁刺激(TMS)
    • 经颅直流电刺激 (tDCS)
  • 神经传导物质检测装置
  • 其他产品类型

第六章全球神经电路市场:依类型

  • 介绍
  • 认知迴路
  • 马达电路
  • 奖励电路
  • 感觉迴路
  • 其他类型

第七章全球神经电路市场:依应用

  • 介绍
  • 临床诊断
  • 药物研发发现与开发
  • 治疗性介入
  • 神经假体
  • 其他用途

第八章全球神经电路市场:依最终用户分类

  • 介绍
  • 医院
  • 研究与开发
  • 復健中心
  • 製药公司
  • 其他最终用户

第九章全球神经电路市场:按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 中东和非洲其他地区

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • BIOPAC Systems, Inc
  • Blackrock Microsystems
  • Brain Vision LLC
  • Cortera Neurotechnologies, Inc
  • CortiCare, Inc
  • G.tec medical engineering GmbH
  • Inscopix, Inc
  • Neuralink Corporation
  • Neurologica Corporation
  • NeuroNexus Technologies
  • NeuroPace, Inc
  • Stoelting Co
Product Code: SMRC24496

According to Stratistics MRC, the Global Neuronal Circuits Market is accounted for $194.7 million in 2023 and is expected to reach $701.7 million by 2030 growing at a CAGR of 20.1% during the forecast period. Neurostimulation devices, neuromodulation technologies, and other interventions for the treatment of diseases including Parkinson's disease, depression, and chronic pain. Imaging technologies, electrodes, probes, neurostimulation devices, and neurotechnological advancements are only a few of the many tools and solutions available. Understanding, modifying, and using neuronal circuits in the nervous system is the focus of the market for neuronal circuits, which includes research, development, and commercialization of associated technologies and products.

Market Dynamics:

Driver:

Growing investments in neuroscience research

Innovation and the creation of cutting-edge technology aimed at understanding and modifying neuronal networks are fueled by increased funding from governmental organizations, private investors, and pharmaceutical corporations. These investments support research exploring neurological conditions, the intricacies of brain function, and potential treatment options. Additionally, more financing enables researchers to execute longer and deeper studies, which results in the development of cutting-edge instruments and gadgets as well as the discovery of novel insights.

Restraint:

Lack of standardization

The lack of standard methods, methodologies, and reporting practices in clinical applications and research inquiries impedes the comparability and reproducibility of results. This diversity makes it difficult to understand the data, which makes it challenging to build standard processes to examine neural circuits in neurons. In addition to making it more difficult for institutions and researchers to collaborate, the lack of standards makes it more complex to convert research findings into therapeutic applications. In order to ensure data authenticity and reliability, promote interdisciplinary collaboration, and accelerate the development of neurotechnologies that may be efficiently integrated into healthcare procedures, standardization is essential.

Opportunity:

Growing aging population

Age-related neurological conditions, such as Alzheimer's disease, Parkinson's disease, and cognitive decline, are on the rise internationally in correlation with the growing number of elderly individuals. Innovative diagnostic instruments, treatment approaches, and neurostimulation devices that can address the complexities of older people's neural circuits are desperately needed as the aging population grows. Moreover, this shift in the population emphasizes the need for neuroscience research and development to provide solutions that are specifically customized to the demands of the aging population.

Threat:

Variable efficacy in clinical settings

Although treating neurological illnesses with these therapies indicates promise, variations in their efficacy may exist. The unpredictable nature of treatment outcomes is attributed to various factors, including human heterogeneity, the complex structure of neural circuits, and the dynamic nature of neurological disorders. The wider use of these technologies is hampered by the variability that presents difficulties for healthcare professionals in anticipating and maximizing the treatment response. Deeper knowledge of the unique properties of each brain circuit, individualized treatment plans, and more research to improve and standardize techniques are necessary for achieving reliable and consistent results.

COVID-19 Impact:

The pandemic-related closure of laboratories and the reallocation of resources toward pandemic-related efforts caused significant disruptions to research and development. Additionally, difficulties in attracting patients and gaining access to research sites caused delays in clinical trials for new neurotechnologies targeting neuronal circuits. Furthermore, the increased awareness of mental health issues brought on by the pandemic also resulted in increased interest in and investment in neurotechnologies addressing conditions like depression and anxiety.

The neurotechnology devices segment is expected to be the largest during the forecast period

Due to remarkable technological developments and an increasing understanding of the critical role neural circuits play in neurological functioning, neurotechnology devices held the largest market share. Brain-computer interfaces (BCIs), neural interfaces, neurostimulation devices, and neuroprosthetics are just a few instances among the many developments that are included under the broad category of neurotechnology devices. Additionally, these gadgets are leading the way in transforming neuroscience research, therapies, and diagnostics. By modifying particular neural circuits, neurostimulation devices like deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS) are being used more often to treat neurological conditions.

The motor circuits segment is expected to have the highest CAGR during the forecast period

Because of the rising awareness of the complexity of motor function and the increasing demand for cutting-edge therapeutic treatments, the motor circuits segment is expected to grow profitably. The development and use of neurotechnologies that target motor circuits, which emphasize the critical role these circuits play in movement control and coordination, is especially notable for this surge. Furthermore, the Motor Circuits portion covers advancements in neuroprosthetics and brain-computer interfaces (BCIs) that directly interface with motor-related neural circuits, providing motor function for individuals who lose their limbs or are paralyzed.

Region with largest share:

The Asia Pacific area held the largest share because of the region's countries' leading positions in the field of neurotechnology innovation, which have been established by significant investments in research and development as well as rapid improvements in healthcare infrastructure. The need for innovative diagnostic and treatment approaches has increased due to an increasing understanding of neurological illnesses and the incidence of illnesses affecting neural circuits. Furthermore, a vibrant ecosystem for neuroscience research is being developed in the Asia-Pacific area through a rise in cooperative initiatives and partnerships between academic institutions, research organizations, and industrial contributors.

Region with highest CAGR:

Because of its heavy emphasis on research funding, healthcare infrastructure, and collaborations, the Europe area is expected to have lucrative growth. European nations have invested heavily in neural circuit research, resulting in advances in the understanding of how the brain works as well as the development of cutting-edge technologies. Furthermore, the growth of cutting-edge neural circuit technology has been fueled by government financing and strategic investments in neuroscience initiatives, which have established a favorable environment for research and development.

Key players in the market:

Some of the key players in Neuronal Circuits market include BIOPAC Systems, Inc, Blackrock Microsystems, Brain Vision LLC, Cortera Neurotechnologies, Inc, CortiCare, Inc, G.tec medical engineering GmbH, Inscopix, Inc, Neuralink Corporation , Neurologica Corporation, NeuroNexus Technologies, NeuroPace, Inc and Stoelting Co.

Key Developments:

In January 2023, NeuroLogica Announces a Research Partnership with the University of Dundee Using State-of-the-Art Photon Counting Detector Technology. The partnership aims to push the boundaries of medical imaging, impact patient outcomes and increase the quality of life for Scottish patients at Dundee.

In November 2022, NeuroLogica Announces FDA 510(k) Clearance of BodyTom 64. The BodyTom 64 was designed to help healthcare professionals bring the power of advanced imaging directly to their patients.

Product Types Covered:

  • Neurotechnology Devices
  • Neurodiagnostics
  • Neurotherapeutics
  • Electrodes and Probes
  • Neurostimulation Devices
  • Neurotransmitter Detection Devices
  • Other Product Types

Types Covered:

  • Cognitive Circuits
  • Motor Circuits
  • Reward Circuits
  • Sensory Circuits
  • Other Types

Applications Covered:

  • Clinical Diagnostics
  • Drug Discovery and Development
  • Therapeutic Interventions
  • Neuroprosthetics
  • Other Applications

End Users Covered:

  • Hospitals
  • Research and Development
  • Rehabilitation Centers
  • Pharmaceutical Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neuronal Circuits Market, By Product Type

  • 5.1 Introduction
  • 5.2 Neurotechnology Devices
  • 5.3 Neurodiagnostics
  • 5.4 Neurotherapeutics
  • 5.5 Electrodes and Probes
    • 5.5.1 Microelectrode arrays
    • 5.5.2 Multielectrode arrays
    • 5.5.3 Patch-clamp electrodes
  • 5.6 Neurostimulation Devices
    • 5.6.1 Deep Brain Stimulation (DBS)
    • 5.6.2 Transcranial Magnetic Stimulation (TMS)
    • 5.6.3 Transcranial Direct Current Stimulation (tDCS)
  • 5.7 Neurotransmitter Detection Devices
  • 5.8 Other Product Types

6 Global Neuronal Circuits Market, By Type

  • 6.1 Introduction
  • 6.2 Cognitive Circuits
  • 6.3 Motor Circuits
  • 6.4 Reward Circuits
  • 6.5 Sensory Circuits
  • 6.6 Other Types

7 Global Neuronal Circuits Market, By Application

  • 7.1 Introduction
  • 7.2 Clinical Diagnostics
  • 7.3 Drug Discovery and Development
  • 7.4 Therapeutic Interventions
  • 7.5 Neuroprosthetics
  • 7.6 Other Applications

8 Global Neuronal Circuits Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Research and Development
  • 8.4 Rehabilitation Centers
  • 8.5 Pharmaceutical Companies
  • 8.6 Other End Users

9 Global Neuronal Circuits Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 BIOPAC Systems, Inc
  • 11.2 Blackrock Microsystems
  • 11.3 Brain Vision LLC
  • 11.4 Cortera Neurotechnologies, Inc
  • 11.5 CortiCare, Inc
  • 11.6 G.tec medical engineering GmbH
  • 11.7 Inscopix, Inc
  • 11.8 Neuralink Corporation
  • 11.9 Neurologica Corporation
  • 11.10 NeuroNexus Technologies
  • 11.11 NeuroPace, Inc
  • 11.12 Stoelting Co

List of Tables

  • Table 1 Global Neuronal Circuits Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Neuronal Circuits Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Neuronal Circuits Market Outlook, By Neurotechnology Devices (2021-2030) ($MN)
  • Table 4 Global Neuronal Circuits Market Outlook, By Neurodiagnostics (2021-2030) ($MN)
  • Table 5 Global Neuronal Circuits Market Outlook, By Neurotherapeutics (2021-2030) ($MN)
  • Table 6 Global Neuronal Circuits Market Outlook, By Electrodes and Probes (2021-2030) ($MN)
  • Table 7 Global Neuronal Circuits Market Outlook, By Microelectrode arrays (2021-2030) ($MN)
  • Table 8 Global Neuronal Circuits Market Outlook, By Multielectrode arrays (2021-2030) ($MN)
  • Table 9 Global Neuronal Circuits Market Outlook, By Patch-clamp electrodes (2021-2030) ($MN)
  • Table 10 Global Neuronal Circuits Market Outlook, By Neurostimulation Devices (2021-2030) ($MN)
  • Table 11 Global Neuronal Circuits Market Outlook, By Deep Brain Stimulation (DBS) (2021-2030) ($MN)
  • Table 12 Global Neuronal Circuits Market Outlook, By Transcranial Magnetic Stimulation (TMS) (2021-2030) ($MN)
  • Table 13 Global Neuronal Circuits Market Outlook, By Transcranial Direct Current Stimulation (tDCS) (2021-2030) ($MN)
  • Table 14 Global Neuronal Circuits Market Outlook, By Neurotransmitter Detection Devices (2021-2030) ($MN)
  • Table 15 Global Neuronal Circuits Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 16 Global Neuronal Circuits Market Outlook, By Type (2021-2030) ($MN)
  • Table 17 Global Neuronal Circuits Market Outlook, By Cognitive Circuits (2021-2030) ($MN)
  • Table 18 Global Neuronal Circuits Market Outlook, By Motor Circuits (2021-2030) ($MN)
  • Table 19 Global Neuronal Circuits Market Outlook, By Reward Circuits (2021-2030) ($MN)
  • Table 20 Global Neuronal Circuits Market Outlook, By Sensory Circuits (2021-2030) ($MN)
  • Table 21 Global Neuronal Circuits Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 22 Global Neuronal Circuits Market Outlook, By Application (2021-2030) ($MN)
  • Table 23 Global Neuronal Circuits Market Outlook, By Clinical Diagnostics (2021-2030) ($MN)
  • Table 24 Global Neuronal Circuits Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
  • Table 25 Global Neuronal Circuits Market Outlook, By Therapeutic Interventions (2021-2030) ($MN)
  • Table 26 Global Neuronal Circuits Market Outlook, By Neuroprosthetics (2021-2030) ($MN)
  • Table 27 Global Neuronal Circuits Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 28 Global Neuronal Circuits Market Outlook, By End User (2021-2030) ($MN)
  • Table 29 Global Neuronal Circuits Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 30 Global Neuronal Circuits Market Outlook, By Research and Development (2021-2030) ($MN)
  • Table 31 Global Neuronal Circuits Market Outlook, By Rehabilitation Centers (2021-2030) ($MN)
  • Table 32 Global Neuronal Circuits Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 33 Global Neuronal Circuits Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.